UnitedHealth (UNH) Under Fire as Senators Demand Answers about Nursing Home Practices
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Allegations and Concerns
The probe claims that UnitedHealth paid nursing homes bonuses for reducing hospital transfers for residents enrolled in its insurance plans. Although this can sometimes help avoid unnecessary hospital visits, the senators worry the real motive was profit, leading to delays in critical care.
In a letter to UnitedHealth, Wyden and Warren expressed alarm, stating that the company's 'incentive schemes may drive delays in medically necessary hospitalizations and emergency room visits' and could result in 'permanent harm' to residents.
They are also concerned about reports that UNH's Optum subsidiary may have pushed residents to sign do-not-resuscitate or do-not-intubate orders, which senators think could be a tactic to cut hospital costs.
To investigate these claims, the senators have asked UnitedHealth to share documents about its nursing home incentive programs, especially those tied to hospital visits. They also want data on the company's marketing and how its nursing home operations are monitored by federal and state regulators. The company has until September 8 to respond.
Legal and Financial Troubles Deepen
This latest probe adds to the growing list of problems UNH is facing. The Department of Justice is already investigating UnitedHealth for potential billing fraud in its Medicare Advantage plans. On top of that, the company faces criticism for allegedly using algorithms to limit patient care and for engaging in potential anti-competitive practices.
UnitedHealth is also struggling financially. The company recently pulled back its profit forecast for 2025 and then issued a lower one after admitting that it had underestimated its medical costs.
With multiple investigations underway and investor confidence shaken, people will keep a close eye on what UnitedHealth does next.
Is UNH a Good Buy Right Now?
Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, three Holds, and two Sells assigned in the last three months. At $313.68, the average UnitedHealth stock price target implies a 25.36% upside potential.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
2 hours ago
- The Hill
HHS pilot program raises Democratic concerns over Medicare red tape
House Democrats are sounding the alarm and demanding more information about a new Department of Health & Human Services (HHS) demonstration they say will increase red tape by adding prior authorization requirements in Medicare. Led by Reps. Suzan DelBene (D-Wash.) and Ami Bera (D-Calif.), a group of 17 Democrats questioned why HHS would want to test adding prior authorization requirements in traditional Medicare when the Trump administration is touting efforts to reduce the practice in Medicare Advantage (MA). Traditional Medicare has rarely required prior authorization, but private MA plans have come under fire for relying on the controversial practice as a tool to increase profits. 'The Trump Administration publicly recognized the harm of prior authorization…And yet, not a week after these statements, CMS put forward a new proposal to increase the utilization of prior authorization in a type of health coverage that had seldom used the tactic before, replacing doctor's medical knowledge with an algorithm designed to maximize care denial in order to increase profits,' the lawmakers wrote in a letter to Centers for Medicare and Medicaid Services Administrator Mehmet Oz. The lawmakers are concerned about a new CMS pilot program to test a model targeting 'wasteful, inappropriate services in Original Medicare.' Under the model, CMS will partner with private companies, including some of the Medicare Advantage plans that are under fire for using prior authorization to deny a clinician's request to provide care. The model will require prior authorization for a list of outpatient procedures that the agency has flagged as vulnerable to fraud, waste and abuse, or inappropriate use. Participants will be rewarded based on the 'effectiveness of their technology solutions' for reducing spending on medically unnecessary or non-covered services. The lawmakers said they were concerned about creating perverse incentives that reward the companies that deny the most care. 'Prior authorization has long been abused, and it is bad for patients and providers,' the lawmakers wrote. An analysis of 2023 HHS data from KFF found about 81 percent of denials were partially or fully overturned after being appealed. 'The use of prior authorization in Medicare Advantage shows us that, in practice, [the demonstration] will likely limit beneficiaries' access to care, increase burden on our already overburdened health care work force, and create perverse incentives to put profit over patients,' the letter stated. The letter asked CMS for details on the pilot's scope, implementation plan and safeguards for beneficiaries. Meanwhile, the Trump administration is touting voluntary pledges they have received from the health insurance industry to streamline and reform the prior authorization process for MA plans. Lawmakers said the move shows the administration recognizes the harms of prior authorization. 'There's violence in the streets over these issues,' Oz said during an event announcing the industry pledges.
Business Insider
3 hours ago
- Business Insider
SPY ETF News, 8/11/2025
How is SPY stock faring? The SPDR S&P 500 ETF Trust has risen 1.63% over the past five days and is up 9.37% year-to-date. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks' unique ETF analyst consensus, which is based on a weighted average of its holdings' analyst ratings, SPY is a Moderate Buy. The Street's average price target of $710.54 for the SPY ETF implies an upside potential of 11.51%. Currently, SPY's five holdings with the highest upside potential are Moderna (MRNA), Charter Communications (CHTR), Eli Lilly (LLY), Caesars Entertainment (CZR), and Loews (L). (PLTR), Garmin (GRMN), Dollar Tree (DLTR), Tesla Motors (TSLA), and Altria (MO). Revealingly, SPY's ETF Smart Score is seven, implying that this ETF is likely to perform in line with the market. Power up your ETF investing with TipRanks. Discover the ETFs with High Upside Potential, carefully curated based on TipRanks' analysis.
Business Insider
4 hours ago
- Business Insider
VOO ETF News, 8/11/2025
How is VOO stock faring? The Vanguard S&P 500 ETF is up 1.66% in the past five days and 9.42% year-to-date. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks' unique ETF analyst consensus, determined based on a weighted average of analyst ratings on its holdings, VOO is a Moderate Buy. The Street's average price target of $656.85 implies an upside of 12.14%. Currently, VOO's five holdings with the highest upside potential are Loews (L), Charter Communications (CHTR), Caesars Entertainment (CZR), Eli Lilly (LLY), and Moderna (MRNA). (PLTR), Dollar Tree (DLTR), Garmin (GRMN), Tesla (TSLA), and Altria (MO). Revealingly, VOO ETF's Smart Score is seven, implying that this ETF will likely perform in line with the market. Does VOO Pay Dividends? SPX). Since company payouts change over time, the dividend amount from VOO also varies each quarter. VOO's yield as of today is 1.18%. Power up your ETF investing with TipRanks. Discover the Top Equity ETFs with High Upside Potential, carefully curated based on TipRanks' analysis.
